MGMT and central nervous system cancer: Wolfgang [28] et al. studied in patients with glioma the effects of the treatment with either an alternating weekly schedule (7 days on/7 days off) or for 21 consecutive days every 28-day cycle (21/28-day schedule) on MGMT enzyme activity assayed in peripheral blood mononuclear cells (PBMCs).